tiprankstipranks
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ:MIRM

Mirum Pharmaceuticals (MIRM) Cash flow

586 Followers

Mirum Pharmaceuticals Cash Flow

MIRM's free cash flow for Q4 2023 was $-21.62M. For the 2023 fiscal year, MIRM's free cash flow was decreased by $29.36M and operating cash flow was $-16.62M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -70.94M$ -70.94M$ -120.14M$ -132.76M$ -89.08M$ -39.36M
Investing Cash Flow
$ -107.20M$ -107.20M$ 7.70M$ 48.55M$ 37.87M$ -127.78M
Financing Cash Flow
$ 336.60M$ 336.60M$ 109.09M$ 73.47M$ 181.29M$ 127.18M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 1.04B$ 286.33M$ 128.00M$ 131.34M$ 142.09M$ 11.97M
Income Tax Paid Supplemental Data
$ 125.00K$ 125.00K--$ 11.00K$ 21.00K
Interest Paid Supplemental Data
$ 6.82M$ 6.82M----
Issuance Of Capital Stock
$ 216.68M$ 216.68M$ 107.37M$ 6.91M$ 131.87M$ 127.18M
Issuance Of Debt
$ 305.30M$ 305.30M---$ 0.00
Repayment Of Debt
------
Free Cash Flow
$ -72.83M$ -91.05M$ -120.41M$ -132.78M$ -89.30M$ -39.64M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Mirum Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis